JOHN DE CSEPEL, MD
Radiology at 96 St, New York, NY
License number
New York 203420
Category
Radiology
Type
Surgery
Address
Address
49 E 96Th St #12A, New York, NY 10128
Phone
(212) 987-8109
Personal information
See more information about JOHN DE CSEPEL at radaris.comName
Address
Phone
New York, NY
49 E 96Th St #12-A, New York, NY 10128
Organization information
See more information about JOHN DE CSEPEL at bizstanding.comJohn De Csepel MD
49 E 96 St #12A, New York, NY 10128
Categories:
General Surgeons
Phone:
(212) 722-7480 (Phone)
Professional information
See more information about JOHN DE CSEPEL at trustoria.com
Senior Medical Director At Barrx Medical
Senior Medical Director At Barrx Medical
Location:
Greater New York City Area
Industry:
Medical Devices
Experience:
Barrx Medical (Privately Held; Medical Devices industry): Senior Medical Director, (January 2007-Present) St. Vincent's Hospital (Non-Profit; Hospital & Health Care industry): Chief of Minimally Invasive Surgery, (November 2001-May 2006)
Dr. John Csepel, New York NY - MD (Doctor of Medicine)
Dr. John Csepel, New York NY - MD (Doctor of Medicine)
Specialties:
General Surgery
Address:
49 E 96Th St SUITE 12A, New York 10128
(212) 987-8109 (Phone)
(212) 987-8109 (Phone)
Certifications:
General Surgery, 2010
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Georgetown University
Mount Sinai Hospital
Georgetown University
Mount Sinai Hospital
Method And Apparatus For Gastrointestinal Tract Ablation To Achieve Loss Of Persistent And/Or Recurrent Excess Body Weight Following A Weight Loss Operation
Method And Apparatus For Gastrointestinal Tract Ablation To Achieve Loss Of Persistent And/Or Recurrent Excess Body Weight Following A Weight Loss Operation
US Patent:
2012028, Nov 15, 2012
Filed:
Jul 26, 2012
Appl. No.:
13/558506
Inventors:
David S. Utley - Redwood City CA, US
John de Csepel - New York NY, US
John de Csepel - New York NY, US
Assignee:
Tyco Healthcare Group, LP - Mansfield MA
International Classification:
A61B 18/18, A61B 18/02
US Classification:
606 21, 606 33
Abstract:
Devices and methods are provided for ablational treatment of regions of the digestive tract in post-bariatric surgery patients who fail to achieve or maintain the desired weight loss. Bariatric procedures include Roux-en-Y gastric bypass, biliopancreatic diversion, and sleeve gastrectomy. These procedures reconstruct gastrointestinal tract features, creating pouches, stoma, and tubes that restrict and/or divert the digestive flow. Post-surgical dilation of altered structures is common and diminishes their bariatric effectiveness. Ablation of compromised structures can reduce their size and compliance, restoring bariatric effectiveness. Ablation, as provided the invention, starts at the mucosa and penetrates deeper into the gastrointestinal wall in a controlled manner. Control may also be provided by a fractional ablation that ablates some tissue within a target region and leaves a portion substantially unaffected. Embodiments of the device include an ablational electrode array that spans 360 degrees and an array that spans an arc of less than 360 degrees.
Selectively Expandable Operative Element Support Structure And Methods Of Use
Selectively Expandable Operative Element Support Structure And Methods Of Use
US Patent:
2012023, Sep 20, 2012
Filed:
Mar 18, 2011
Appl. No.:
13/051738
Inventors:
Michael P. Wallace - Pleasanton CA, US
Robert Garabedian - Sunnyvale CA, US
David S. Utley - Redwood City CA, US
Brent C. Gerberding - San Jose CA, US
John de Csepel - New York NY, US
Robert Garabedian - Sunnyvale CA, US
David S. Utley - Redwood City CA, US
Brent C. Gerberding - San Jose CA, US
John de Csepel - New York NY, US
International Classification:
A61B 18/18, A61M 29/00
US Classification:
606 41, 606198
Abstract:
In one embodiment, a device is provided including an expandable support member having a first portion and a second portion is provided. The first portion is adapted to have a smaller expansion index than the second portion. A therapeutic or diagnostic instrument is supported, at least in part, by the expandable support member first portion. In another embodiment, the support member is adapted for non-uniform expansion of the first and second portions. There are also described methods of forming therapeutic devices. There are also described methods of providing therapy to tissue in a body by positioning a device in proximity to tissue in a body selected to receive therapy. Next, the expandable support member second portion is expanded until the instrument is at a therapeutic position relative to the tissue in a body selected to receive therapy. Thereafter, therapy or diagnosis is provided to the selected tissue using the device.
Method And Apparatus For Gastrointestinal Tract Ablation To Achieve Loss Of Persistent And/Or Recurrent Excess Body Weight Following A Weight-Loss Operation
Method And Apparatus For Gastrointestinal Tract Ablation To Achieve Loss Of Persistent And/Or Recurrent Excess Body Weight Following A Weight-Loss Operation
US Patent:
2009001, Jan 8, 2009
Filed:
Jul 3, 2008
Appl. No.:
12/167902
Inventors:
David S. Utley - Redwood City CA, US
John de Csepel - New York NY, US
John de Csepel - New York NY, US
International Classification:
A61B 18/04, A61B 18/02
US Classification:
606 21, 606 34
Abstract:
Devices and methods are provided for ablational treatment of regions of the digestive tract in post-bariatric surgery patients who fail to achieve or maintain the desired weight loss. Bariatric procedures include Roux-en-Y gastric bypass, biliopancreatic diversion, and sleeve gastrectomy. These procedures reconstruct gastrointestinal tract features, creating pouches, stoma, and tubes that restrict and/or divert the digestive flow. Post-surgical dilation of altered structures is common and diminishes their bariatric effectiveness. Ablation of compromised structures can reduce their size and compliance, restoring bariatric effectiveness. Ablation, as provided the invention, starts at the mucosa and penetrates deeper into the gastrointestinal wall in a controlled manner. Control may also be provided by a fractional ablation that ablates some tissue within a target region and leaves a portion substantially unaffected. Embodiments of the device include an ablational electrode array that spans 360 degrees and an array that spans an arc of less than 360 degrees.